HUTCHMED (China) Limited
HUTCHMED (China) Limited (HCM) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HCM · as of Sep 30, 2025
Ownership Breakdown
55
Institutional Holders
▼ 6 vs Q2
$90.66M
Total Inst. Value
▼ $748,496 vs Q2
174.47M
Shares Outstanding
freeFloat 97.70%
5.76M
13F Shares Held
▼ 307,899 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HCM largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SCHRODER INVESTMENT MANAGEMENT GROUP pharmaceutical preparations | 2.47M | 1.41% | 1.41% | $38.64B | Nov 13, 2025 | ▼ 112.2K |
ALLIANZ ASSET MANAGEMENT GMBH pharmaceutical preparations | 908.8K | 51.94% | 51.94% | $14.31B | Nov 4, 2025 | ▼ 15.7K |
JANE STREET GROUP, LLC pharmaceutical preparations | 340.3K | 19.45% | 19.45% | $5.36B | Nov 14, 2025 | ▲ 164.4K |
STATE STREET CORP pharmaceutical preparations | 317.5K | 18.14% | 18.14% | $5.00B | Nov 14, 2025 | ▼ 11.3K |
AIA GROUP LTD pharmaceutical preparations | 315.4K | 18.03% | 18.03% | $4.97B | Dec 18, 2025 | — held |
AMUNDI pharmaceutical preparations | 223.3K | 12.76% | 12.76% | $3.62B | Nov 14, 2025 | ▲ 65.9K |
M&G PLC pharmaceutical preparations | 204.4K | 11.68% | 11.68% | $3.27B | Nov 7, 2025 | ▼ 55.2K |
UBS GROUP AG pharmaceutical preparations | 137.0K | 7.83% | 7.83% | $2.16B | Nov 13, 2025 | ▲ 72.6K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 131.0K | 7.49% | 7.49% | $2.06B | Nov 13, 2025 | ▲ 2.0K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 82.3K | 4.70% | 4.70% | $1.30B | Nov 14, 2025 | ▼ 12.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
20
Increased
+361.4K shares2
New Positions
first time holders20
Decreased
−258.8K shares0
Sold Out
fully exitedNet shares change (top 50)
+102.6K
+361.4K / −258.8K
Net new holders
+2
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HCM insider trading · insider activity
Source: SEC Form 4
8
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Cheng Chig Fung Acting CEO and CFO | May 20, 2026 | J-Other | 30,157 | — | — | 30.2K | Form 4 ↗ |
Cheng Chig Fung Acting CEO and CFO | May 20, 2026 | J-Other | 26,307 | — | — | 26.3K | Form 4 ↗ |
Nixon Charles George Rupert Group General Counsel | May 20, 2026 | J-Other | 7,644 | — | — | 7.6K | Form 4 ↗ |
Nixon Charles George Rupert Group General Counsel | May 20, 2026 | J-Other | 7,445 | — | — | 7.4K | Form 4 ↗ |
Su Wei-guo CEO and CSO | May 20, 2026 | J-Other | 132,864 | — | — | 132.9K | Form 4 ↗ |
Su Wei-guo CEO and CSO | May 20, 2026 | J-Other | 75,140 | — | — | 75.1K | Form 4 ↗ |
Chiu Lorenso Deputy Chief Financial Officer | May 20, 2026 | J-Other | 8,863 | — | — | 8.9K | Form 4 ↗ |
Chiu Lorenso Deputy Chief Financial Officer | May 20, 2026 | J-Other | 5,176 | — | — | 5.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
HUTCHMED (China) Limited (HCM) is primarily owned by institutional investors, who hold approximately 3.3% of total shares outstanding. Company insiders own approximately 2.30%, while retail and public investors account for the remaining 94.40%.
The largest institutional shareholder of HUTCHMED (China) Limited is SCHRODER INVESTMENT MANAGEMENT GROUP, holding approximately 2.47 million shares — equal to 1.41% of outstanding shares — as of September 30, 2025.
A total of 55 institutional investors currently hold HCM stock, with a combined institutional value of approximately $90,656,720 as of the most recent 13F filing period.
Frequently asked questions
HCM ownershipHUTCHMED (China) Limited (HCM) is primarily owned by institutional investors, who hold approximately 3.3% of shares. The largest shareholder is SCHRODER INVESTMENT MANAGEMENT GROUP with a 1.41% stake. Company insiders hold 2.30%. Data sourced from SEC Form 13F as of September 30, 2025.